Dong-E-E-JiaoLtd Future Growth
Future criteria checks 2/6
Dong-E-E-JiaoLtd is forecast to grow earnings and revenue by 16.7% and 15.7% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 16% in 3 years.
Key information
16.7%
Earnings growth rate
16.1%
EPS growth rate
| Pharmaceuticals earnings growth | 19.4% |
| Revenue growth rate | 15.7% |
| Future return on equity | 16.0% |
| Analyst coverage | Good |
| Last updated | 06 Sep 2024 |
Recent future growth updates
Recent updates
Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Shares Could Be 37% Below Their Intrinsic Value Estimate
Sep 13
Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results
Mar 25Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio
Mar 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,762 | 2,043 | 1,949 | 1,435 | 11 |
| 12/31/2025 | 6,644 | 1,715 | 1,604 | 1,702 | 12 |
| 12/31/2024 | 5,632 | 1,447 | 1,352 | 1,252 | 9 |
| 6/30/2024 | 5,296 | 1,358 | 2,054 | 2,123 | N/A |
| 3/31/2024 | 5,100 | 1,274 | 1,851 | 1,914 | N/A |
| 12/31/2023 | 4,715 | 1,151 | 1,899 | 1,953 | N/A |
| 9/30/2023 | 4,424 | 1,051 | 2,099 | 2,144 | N/A |
| 6/30/2023 | 4,383 | 1,003 | 2,142 | 2,189 | N/A |
| 3/31/2023 | 4,220 | 896 | 2,326 | 2,376 | N/A |
| 1/1/2023 | 4,042 | 780 | 2,099 | 2,145 | N/A |
| 9/30/2022 | 4,070 | 652 | 1,661 | 1,705 | N/A |
| 6/30/2022 | 3,988 | 599 | 1,436 | 1,476 | N/A |
| 3/31/2022 | 4,006 | 493 | 2,117 | 2,142 | N/A |
| 1/1/2022 | 3,849 | 440 | 2,776 | 2,801 | N/A |
| 9/30/2021 | 4,195 | 366 | 3,118 | 3,153 | N/A |
| 6/30/2021 | 4,001 | 277 | 2,420 | 2,473 | N/A |
| 3/31/2021 | 3,705 | 189 | 1,626 | 1,691 | N/A |
| 12/31/2020 | 3,409 | 43 | 698 | 801 | N/A |
| 9/30/2020 | 2,181 | -685 | -174 | -6 | N/A |
| 6/30/2020 | 2,175 | -732 | -62 | 217 | N/A |
| 3/31/2020 | 2,116 | -932 | -594 | -271 | N/A |
| 12/31/2019 | 2,970 | -455 | -1,459 | -1,119 | N/A |
| 9/30/2019 | 5,784 | 1,069 | 813 | 1,101 | N/A |
| 6/30/2019 | 6,243 | 1,416 | 667 | 915 | N/A |
| 3/31/2019 | 6,934 | 1,869 | 507 | 764 | N/A |
| 12/31/2018 | 7,338 | 2,085 | 760 | 1,009 | N/A |
| 9/30/2018 | 7,276 | 2,023 | 749 | 1,024 | N/A |
| 6/30/2018 | 7,424 | 2,005 | 1,186 | 1,467 | N/A |
| 3/31/2018 | 7,392 | 2,049 | N/A | 1,226 | N/A |
| 12/31/2017 | 7,372 | 2,044 | N/A | 1,757 | N/A |
| 9/30/2017 | 6,813 | 1,873 | N/A | 901 | N/A |
| 6/30/2017 | 6,577 | 1,925 | N/A | 943 | N/A |
| 3/31/2017 | 6,510 | 1,913 | N/A | 1,444 | N/A |
| 12/31/2016 | 6,317 | 1,852 | N/A | 625 | N/A |
| 9/30/2016 | 5,649 | 1,721 | N/A | 97 | N/A |
| 6/30/2016 | 5,577 | 1,682 | N/A | 133 | N/A |
| 3/31/2016 | 5,501 | 1,643 | N/A | 561 | N/A |
| 12/31/2015 | 5,450 | 1,625 | N/A | 978 | N/A |
| 9/30/2015 | 5,190 | 1,572 | N/A | 1,053 | N/A |
| 6/30/2015 | 4,830 | 1,516 | N/A | 511 | N/A |
| 3/31/2015 | 4,494 | 1,464 | N/A | 501 | N/A |
| 12/31/2014 | 4,009 | 1,366 | N/A | 657 | N/A |
| 9/30/2014 | 3,769 | 1,265 | N/A | 674 | N/A |
| 6/30/2014 | 3,990 | 1,282 | N/A | 1,192 | N/A |
| 3/31/2014 | 3,995 | 1,247 | N/A | 1,092 | N/A |
| 12/31/2013 | 4,016 | 1,203 | N/A | 879 | N/A |
| 9/30/2013 | 4,047 | 1,162 | N/A | 803 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000423's forecast earnings growth (16.7% per year) is above the savings rate (2.9%).
Earnings vs Market: 000423's earnings (16.7% per year) are forecast to grow slower than the CN market (23.2% per year).
High Growth Earnings: 000423's earnings are forecast to grow, but not significantly.
Revenue vs Market: 000423's revenue (15.7% per year) is forecast to grow faster than the CN market (13.3% per year).
High Growth Revenue: 000423's revenue (15.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 000423's Return on Equity is forecast to be low in 3 years time (16%).